Market Overview

Cigna Says End To ACA Subsidies Would Likely Increase Premiums

Share:
Cigna Says End To ACA Subsidies Would Likely Increase Premiums

The Trump Administration’s decision to discontinue Affordable Care Act subsidy payments would have dramatic implications on insurers and consumers alike, according to CIGNA Corporation (NYSE: CI).

“Many Americans in the Individual insurance market rely on the federal government’s cost-sharing reduction payments to help make their Exchange coverage more affordable,” Cigna spokesperson Mark Slitt told Benzinga. “Recent developments regarding these cost-sharing reduction payments bring further uncertainty to the long-term sustainability of the Individual insurance market, creating likely increases in future premiums.”

The firm appealed to policy makers to collaborate on solutions ensuring financially accessible coverage to millions reliant on Individual insurance.

“In the meantime, Cigna will continue to honor the commitments that we have made to our customers who qualify for cost-sharing reduction payments,” Slitt said.

Related: 7 Stocks To Watch Ahead Of The 60 Minutes DEA-Opioid Exposé

Health insurance stocks were trading lower on the news.

Aetna Inc (NYSE: AET) and UnitedHealth Group Inc (NYSE: UNH) had yet to report their reactions or strategies surrounding the White House's pullback, which CNBC reported Friday.

The subsidies had long appeared secure, as President Donald Trump authorized payments every month despite his enduring resistance to Obamacare. But on Friday, Trump reaffirmed commitment to “repeal and replace."

Photo credit: Emily Elconin

Posted-In: ACA Affordable Care Act Donald TrumpNews Health Care Politics Exclusives General Best of Benzinga

 

Related Articles (CI)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com